• last month
Shares of major vaccine companies fell Thursday after President-elect Donald Trump nominated Robert F. Kennedy Jr., a well-known vaccine skeptic, to lead the Department of Health and Human Services. The stocks of Moderna, Novavax, Pfizer, and BioNTech declined sharply, as reports emerged of Kennedy's nomination. Experts warn a second Trump term could amplify Kennedy's anti-vaccine stance, potentially discouraging Covid and routine vaccinations that have historically prevented severe illnesses and saved lives.
Transcript
00:00It's Benzinga bringing Wall Street to Main Street.
00:02Shares of major vaccine companies fell Thursday after President-elect Donald Trump
00:06nominated Robert F. Kennedy Jr., a well-known vaccine skeptic, to lead the Department of
00:10Health and Human Services. The stocks of Moderna, Novavax, Pfizer, and BioNTech declined sharply
00:16as reports emerged of Kennedy's nomination. Experts warn a second Trump term could amplify
00:21Kennedy's anti-vaccine stance, potentially discouraging COVID and routine vaccinations
00:26that have historically prevented severe illnesses and saved lives.
00:30For all things money, visit Benzinga.com slash GSTV.

Recommended